image
Healthcare - Biotechnology - NASDAQ - US
$ 0.6142
-4.72 %
$ 3 M
Market Cap
-0.05
P/E
INCOME STATEMENT
0 REVENUE
0.00%
-15.7 M OPERATING INCOME
28.18%
-15.2 M NET INCOME
29.84%
EFFICIENCY
Earnings Waterfall Virpax Pharmaceuticals, Inc.
image
Revenue 0
Cost Of Revenue 0
Gross Profit 0
Operating Expenses 15.7 M
Operating Income -15.7 M
Other Expenses -500 K
Net Income -15.2 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
REVENUE
Revenue 0 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0
OPERATING INCOME
Operating Expenses 15.7 21.8 12.0 4.2 3.2 2.6
Selling, General and Administrative Expenses 11.8 11.1 7.2 2.9 2.6 1.5
Research and Development Expenses 5.1 10.8 4.8 1.3 0.6 1.1
Operating Income (15.7) (21.8) (12.0) (4.2) (3.2) (2.6)
PRE-TAX INCOME
Interest Income Expense 0 (0.2) 92.8 K 0.1 0.1 15 K
Total Other Income 0.5 0.2 30.6 K (0.1) (0.1) 15 K
Pre-Tax Income (15.2) (21.7) (12.1) (4.3) (3.3) (2.6)
NET INCOME
Tax Provision 0 (0.2) 92.8 K 0.1 0.1 (0.2)
Net Income (15.2) (21.5) (12.1) (4.5) (3.4) (2.6)
EPS 13 18.3 10.4 9.07 6.58 0.53